At the virtual ASMS 2020 Reboot conference, Bruker (MA, USA) announced the first commercially available matrix-assisted laser desorption ionization-2 (MALDI-2) source, along with the innovations in Bruker’s proteomics platforms.
Thermo Fisher Scientific (MA, USA) has expanded its Orbitrap platform with the release of new software functionalities and two new generation high-resolution mass spectrometers, which are being showcased at ASMS 2020 Reboot.
Almost nothing is known about the importance of protein PTMs in ALS disease progression. Ben Orsburn (Chief Scientist, Proteomic und Genomic Sciences, MD, USA) is inviting you to change that. In this editorial discover the #ALSMinePTMs community project.
Proteomics-based tumor biomarker discovery has come a long way since the days of two-dimensional gels. A multi-biomarker panel could incorporate different classes of biomolecules so as to narrate the disease history in a holistic manner.
This exclusive editorial explores the very recent and very exciting developments in the field of single cell proteomics. Is now the time to realize the potential of SCoPE-MS?
Quantitative proteomics identifies biomarker for acute rickettsial spotted fever infections, say researchers
Researchers based at University of Texas Medical Branch (TX, USA) report the use of quantitative proteomics studies to identify a potential biomarker for rickettsial infections, including Mediterranean spotted fever and Rocky Mountain spotted fever.
Standard-flow LC and thermal focusing ESI elucidates altered liver proteins in late stage Niemann–Pick, type C1 disease
Learn more about the use of standard-flow ESI in quantitative proteomic studies and the identification of new NPC1 protein markers in this research article from Bioanalysis.
A new proteomics technique, termed ubiquitin clipping, has been developed to further understanding of changes that control protein function and their role in healthy and disease states.
As part of our mini-Spotlight on proteomics, we carried out a survey to gain an insight into the trends, challenges and developments associated with proteomics R&D – find out the results in this informative infographic.
We look at some of the highlights of our Twitter chat (#TalkProteomics), where we questioned panelists John Wilson, Ben Orsburn, Matthias Trost and Eduardo Chicano Gálvez about all things proteomics – from mass spectrometry to drug discovery.